We report a novel nanoparticle that is promising for photodynamic therapy applications, which consists of a π-conjugated polymer doped with a singlet oxygen photosensitizer. The nanoparticles exhibit highly efficient collection of excitation light due to the large excitation cross-section of the polymer. A quantum efficiency of singlet oxygen production of 0.5 was determined. Extraordinarily large two-photon excitation cross-sections were determined, indicating promise for near infrared multiphoton photodynamic therapy. Gel electrophoresis of DNA after near-UV irradiation in the presence of nanoparticles indicated both purine base and backbone DNA damage.
Conjugated polymer nanoparticles with incorporated antifade agents were prepared, and ensemble and single particle measurements showed that incorporation of antifade agents effectively improves the fluorescence quantum yield and photostability of the conjugated polymer nanoparticles, likely by a combination of triplet quenching and suppression of processes involved in photogeneration of hole polarons (cations), which act as fluorescence quenchers. The photostability of conjugated polymer nanoparticles and CdSe quantum dots was compared, at both the ensemble and single particle level. The results provide confirmation of the hypothesis that quenching by photogenerated hole polarons is a key factor limiting the fluorescence quantum yield and maximum emission rate in conjugated polymer nanoparticles. Additionally, the results indicate the involvement of oxygen in photogeneration of hole polarons. The results also provide insight into the origin of quenching processes that could limit the performance of conjugated polymer devices.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.